EC Number |
Inhibitors |
Structure |
---|
3.2.1.63 | (2R,3R,4R,5R,6S)-2-(aminomethyl)-6-methylpiperidine-3,4,5-triol |
- |
|
3.2.1.63 | (2R,3S,4S,5R,6S)-2-benzyl-6-methylpiperidine-3,4,5-triol |
- |
|
3.2.1.63 | (2S,3R,4S,5S,6R)-2-methyl-6-(propan-2-yl)piperidine-3,4,5-triol |
- |
|
3.2.1.63 | 2-(1H-indol-3-yl)-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]acetamide |
- |
|
3.2.1.63 | 2-cyclopentyl-2-phenyl-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]acetamide |
- |
|
3.2.1.63 | 3'-fucosyllactose |
- |
|
3.2.1.63 | 3-(1H-indol-3-yl)-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]propanamide |
- |
|
3.2.1.63 | 9-oxo-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]-9H-fluorene-1-carboxamide |
- |
|
3.2.1.63 | alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-GlcNAc |
i.e. blood group antigen B-tetraose type 2 |
|
3.2.1.63 | alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-GlcNAc |
i.e. blood group antigen A-tetraose type 2 |
|